Chester A. Mathis

Active 1977–2025

178
Papers
45,323
Citations
101
h-index
166
i10-index

Citations

Citations per year for Chester A. Mathis1940: 1 citations1979: 1 citations1980: 2 citations1981: 4 citations1982: 2 citations1983: 2 citations1984: 3 citations1985: 7 citations1986: 8 citations1987: 6 citations1988: 7 citations1989: 6 citations1990: 6 citations1991: 9 citations1992: 10 citations1993: 13 citations1994: 14 citations1995: 9 citations1996: 14 citations1997: 16 citations1998: 16 citations1999: 19 citations2000: 32 citations2001: 50 citations2002: 88 citations2003: 140 citations2004: 180 citations2005: 223 citations2006: 272 citations2007: 517 citations2008: 644 citations2009: 957 citations2010: 901 citations2011: 1,234 citations2012: 1,090 citations2013: 988 citations2014: 820 citations2015: 674 citations2016: 733 citations2017: 693 citations2018: 647 citations2019: 1,352 citations2020: 1,379 citations2021: 1,315 citations2022: 972 citations2023: 710 citations2024: 1,063 citations2025: 644 citations2026: 24 citations1941–1978: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 5,597 citing papers, 32.3% of this breakdownUnited Kingdom: 1,557 citing papers, 9% of this breakdownGermany: 967 citing papers, 5.6% of this breakdownSweden: 823 citing papers, 4.7% of this breakdownChina: 811 citing papers, 4.7% of this breakdownCanada: 720 citing papers, 4.2% of this breakdownAustralia: 653 citing papers, 3.8% of this breakdownNetherlands: 612 citing papers, 3.5% of this breakdownItaly: 598 citing papers, 3.5% of this breakdownFrance: 582 citing papers, 3.4% of this breakdownSpain: 476 citing papers, 2.7% of this breakdownJapan: 455 citing papers, 2.6% of this breakdown
0%32.3%Other 20%

Fields

  • Medicine66.5%
  • Neuroscience20.3%
  • Biochemistry, Genetics and Molecular Biology6.1%
  • Psychology2.7%
  • Computer Science1.2%
  • Health Professions0.5%
  • Other2.7%

Topics

  • Alzheimer's disease research and treatments16.9%
  • Dementia and Cognitive Impairment Research12.8%
  • Functional Brain Connectivity Studies5.4%
  • Neuroinflammation and Neurodegeneration Mechanisms2.4%
  • Advanced Neuroimaging Techniques and Applications2.3%
  • Neuroscience and Neuropharmacology Research2.2%
  • Other58%

Coauthors

All papers

Open in search
  1. The Centiloid Project: Standardizing quantitative amyloid plaque estimation by PET

    Authors: , , , , , , , , , , , , - Alzheimer s & Dementia 2014 cited by 1,326

  2. Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B

    Authors: , , , , , , , , , , , , , , , , , , , , - Annals of Neurology 2004 cited by 4,477

  3. Multisite study of the relationships between antemortem [11C]PIB‐PET Centiloid values and postmortem measures of Alzheimer's disease neuropathology

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Salvatore Spina, Prashanthi Vemuri, Victor L. Villemagne, Melissa E. Murray, Gil D. Rabinovici - Alzheimer s & Dementia 2018 cited by 326

  4. Molecular, Structural, and Functional Characterization of Alzheimer's Disease: Evidence for a Relationship between Default Activity, Amyloid, and Memory

    Authors: , , , , , , , , , , - Journal of Neuroscience 2005 cited by 2,147

  5. Amyloid-β Imaging with Pittsburgh Compound B and Florbetapir: Comparing Radiotracers and Quantification Methods

    Authors: , , , , , , - Journal of Nuclear Medicine 2012 cited by 477

  6. Dynamics of the Microglial/Amyloid Interaction Indicate a Role in Plaque Maintenance

    Authors: , , , , , , , , - Journal of Neuroscience 2008 cited by 536

  7. The Alzheimer's Disease Neuroimaging Initiative 2 PET Core: 2015

    Authors: , , , , , , , , - Alzheimer s & Dementia 2015 cited by 304

  8. Frequent Amyloid Deposition Without Significant Cognitive Impairment Among the Elderly

    Authors: , , , , , , , , , , , , , , , - Archives of Neurology 2008 cited by 1,054

  9. Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Aβ 42 in humans

    Authors: , , , , , , , , , , , , - Annals of Neurology 2005 cited by 1,253

  10. Fibrillar amyloid-β burden in cognitively normal people at 3 levels of genetic risk for Alzheimer's disease

    Authors: , , , , , , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2009 cited by 798

  11. Regional variability of imaging biomarkers in autosomal dominant Alzheimer’s disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Bernardino Ghetti, Andrew J. Saykin, Reisa A. Sperling, Keith A. Johnson, Stephen Salloway, Stephen Correia, Peter R. Schofield, Colin L. Masters, Christopher C. Rowe, Victor L. Villemagne, Ralph N. Martins, Sébastien Ourselin, Martin N. Rossor, Nick C. Fox, David M. Cash, Michael W. Weiner, David M. Holtzman, Virginia Buckles, Krista L. Moulder, John C. Morris - National Academy of Sciences, Proceedings of the National Academy of Sciences 2013 cited by 388

  12. Amyloid burden and neural function in people at risk for Alzheimer's Disease

    Authors: , , , , , , , , , , , , , , , , , , , , , - Neurobiology of Aging 2013 cited by 228

  13. Longitudinal assessment of Aβ and cognition in aging and Alzheimer disease

    Authors: , , , , , , , , , , , , , , , , - Annals of Neurology 2011 cited by 830

  14. Validating novel tau positron emission tomography tracer [F‐18]‐AV‐1451 (T807) on postmortem brain tissue

    Authors: , , , , , , , , , , , , , , , , , - Annals of Neurology 2015 cited by 626

  15. SNMMI Procedure Standard/EANM Practice Guideline for Amyloid PET Imaging of the Brain 1.0

    Authors: , , , , , , , , , , , , - Journal of Nuclear Medicine 2016 cited by 258

  16. 11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment

    Authors: , , , , , , , , , , - Brain 2008 cited by 967

  17. The Alzheimer's Disease Neuroimaging Initiative positron emission tomography core

    Authors: , , , , , , , , , , - Alzheimer s & Dementia 2010 cited by 538

  18. Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease

    Authors: , , , , , , , , , , , , , , - Brain 2008 cited by 928

  19. Episodic memory loss is related to hippocampal-mediated -amyloid deposition in elderly subjects

    Authors: , , , , , , , , , , - Brain 2008 cited by 705

  20. Comparison of amyloid burden in individuals with Down syndrome versus autosomal dominant Alzheimer's disease: a cross-sectional study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Howard Andrews, Karen L. Bell, Rasmus M. Birn, Peter Bulova, Amrita K. Cheema, Kewei Chen, I. C. H. Clare, Lorraine N. Clark, Ann D. Cohen, John N. Constantino, Eric Doran, Eleanor Feingold, Tatiana Foroud, Sigan L. Hartley, Christy Hom, Lawrence S. Honig, Miloš D. Ikonomović, Sterling C. Johnson, Courtney Jordan, M. Ilyas Kamboh, David B. Keator, William E. Klunk, Julia Kofler, William Charles Kreisl, Sharon J Krinsky- McHale, Patrick J. Lao, Charles M. Laymon, Ira T. Lott, Victoria Lupson, Chester A. Mathis, Davneet Minhas, Neelesh Nadkarni, Deborah Pang, Melissa Petersen, Julie C. Price, Margaret Pulsifer, Eric M. Reiman, Batool Rizvi, Marwan N. Sabbagh, Nicole Schupf, Dana Tudorascu, Rameshwari V. Tumuluru, Benjamin Tycko, Badri Varadarajan, Desirée A. White, Michael A. Yassa, Shahid Zaman, Fan Zhang, Sarah Adams, Ricardo Allegri, Aki Araki, Nicolas R. Barthélemy, Jacob Bechara, Sarah Berman, Courtney Bodge, Susan E. Brandon, William S. Brooks, Jared R. Brosch, Jill Buck, Virginia Buckles, Kathleen Carter, Lisa Cash, Patricio Chrem Méndez, Jasmin Chua, Helena C. Chui, Laura Courtney, Gregory S. Day, Chrismary DeLaCruz, Darcy Denner, Anna Diffenbacher and 101 more - The Lancet Neurology 2022 cited by 56

  21. Synthesis and Evaluation of 11C-Labeled 6-Substituted 2-Arylbenzothiazoles as Amyloid Imaging Agents

    Authors: , , , , , - Journal of Medicinal Chemistry 2003 cited by 983

  22. Direct Comparison of the Tau PET Tracers18F-Flortaucipir and18F-MK-6240 in Human Subjects

    Authors: , , , , , , , , , , , , , - Journal of Nuclear Medicine 2021 cited by 94

  23. [ 11 C]PIB in a nondemented population

    Authors: , , , , , , , , , - Neurology 2006 cited by 1,033

  24. Characterizing the emergence of amyloid and tau burden in Down syndrome

    Authors: , , , , , , , , , , , , , , , , - Alzheimer s & Dementia 2023 cited by 63